相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen J. Kaar et al.
NEUROPHARMACOLOGY (2020)
Structural equilibrium underlying ligand-dependent activation of β2-adrenoreceptor
Shunsuke Imai et al.
NATURE CHEMICAL BIOLOGY (2020)
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
Luyu Fan et al.
NATURE COMMUNICATIONS (2020)
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen et al.
NATURE CHEMICAL BIOLOGY (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane
Jie Yin et al.
NATURE (2020)
Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
Dohyun Im et al.
NATURE COMMUNICATIONS (2020)
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Terakado Kimura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole
Carmen Klein Herenbrink et al.
ACS CHEMICAL BIOLOGY (2019)
Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Marton Vass et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy et al.
NATURE CHEMICAL BIOLOGY (2018)
KAMO: towards automated data processing for microcrystals
Keitaro Yamashita et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Binding kinetics of cariprazine and aripiprazole at the dopamine D-3 receptor
Annika Frank et al.
SCIENTIFIC REPORTS (2018)
Dopamine D1 or D2 receptor-expressing neurons in the central nervous system
Xiaoyan Wei et al.
ADDICTION BIOLOGY (2018)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The influence of the glutamatergic system on cognition in schizophrenia: A systematic review
Elizabeth H. X. Thomas et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists
Xin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice
Pelin Tanyeri et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Clozapine, a Fast-Off-D2 Antipsychotic
Philip Seeman
ACS CHEMICAL NEUROSCIENCE (2014)
Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT6 and Dopamine D2 Receptor Ligands
Niels Krogsgaard-Larsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography
James Foadi et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
Structure-Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists
Xin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Serotonin 2A receptor antagonists for treatment of schizophrenia
Bjorn H. Ebdrup et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Partial agonists in schizophrenia - why some work and others do not: insights from preclinical animal models
Sridhar Natesan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
John A. Allen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integration, scaling, space-group assignment and post-refinement
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
Bela Kiss et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Crystallizing membrane proteins using lipidic mesophases
Martin Caffrey et al.
NATURE PROTOCOLS (2009)
WAY-100635 has high selectivity for serotonin 5-HT1A versus dopamine D4 receptors
Jean-Claude Martel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia:: A triple tracer PET study
David Mamo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties
Laurent Bardin et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors:: Comparing aripiprazole to other antipsychotics in animal models
Sridhar Natesan et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine
Robert S. Kern et al.
PSYCHOPHARMACOLOGY (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
JM Meyer et al.
SCHIZOPHRENIA RESEARCH (2005)
Novel antipsychotic agents with 5-HT1A agonist properties:: Role of 5-HT1A receptor activation in attenuation of catalepsy induction in rats
MS Kleven et al.
NEUROPHARMACOLOGY (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Dopamine partial agonists - A new class of antipsychotic
JA Lieberman
CNS DRUGS (2004)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Is there a role for 5-HT1A agonists in the treatment of depression?
P Blier et al.
BIOLOGICAL PSYCHIATRY (2003)
Aripiprazole: A third generation of Antipsychotics begins?
NL Keltner et al.
PERSPECTIVES IN PSYCHIATRIC CARE (2002)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
JM Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
分享论文
